Additionally, tumor cells may develop resistance by suppressing CD4+ and CD8+ T cells via immunosuppressive cytokines (such as IL-10), factors regulating lymphocyte chemotaxis or immune check points such as programmed cell death protein 1 (PD1) facilitating the differentiation of immunosuppressive regulatory T cells [13]. The gene discussed is CD8A; the disease is neoplasm.